GB202314911D0 - Dosing of 5-MeO-DMT - Google Patents
Dosing of 5-MeO-DMTInfo
- Publication number
- GB202314911D0 GB202314911D0 GBGB2314911.5A GB202314911A GB202314911D0 GB 202314911 D0 GB202314911 D0 GB 202314911D0 GB 202314911 A GB202314911 A GB 202314911A GB 202314911 D0 GB202314911 D0 GB 202314911D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dmt
- meo
- dosing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- ZSTKHSQDNIGFLM-UHFFFAOYSA-N 5-methoxy-N,N-dimethyltryptamine Chemical compound COC1=CC=C2NC=C(CCN(C)C)C2=C1 ZSTKHSQDNIGFLM-UHFFFAOYSA-N 0.000 title 2
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2314911.5A GB202314911D0 (en) | 2023-09-28 | 2023-09-28 | Dosing of 5-MeO-DMT |
| PCT/GB2024/052500 WO2025068714A1 (en) | 2023-09-28 | 2024-09-27 | Pharmaceutical compositions comprising 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2314911.5A GB202314911D0 (en) | 2023-09-28 | 2023-09-28 | Dosing of 5-MeO-DMT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202314911D0 true GB202314911D0 (en) | 2023-11-15 |
Family
ID=88696336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2314911.5A Ceased GB202314911D0 (en) | 2023-09-28 | 2023-09-28 | Dosing of 5-MeO-DMT |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB202314911D0 (en) |
-
2023
- 2023-09-28 GB GBGB2314911.5A patent/GB202314911D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287838A (en) | Dosing of kras inhibitor for treatment of cancers | |
| IL315404A (en) | Non-linear dosing of mirdametinib | |
| IL322816A (en) | Dosage forms of mirdametinib | |
| IL291273A (en) | Intranasal administration of esketamine | |
| GB201904612D0 (en) | Reaction of glycoladehyde | |
| IL304159A (en) | Composition of bl-8040 | |
| GB202411655D0 (en) | Application of circHIF1a | |
| IL290324A (en) | Compositions of trofinetide | |
| KR102423280B9 (en) | Sot-mram area-optimized design of sot-mram | |
| GB201916428D0 (en) | Treatment of hydro-carbon-contaminated materials | |
| GB202103774D0 (en) | Detectiion of Ransomware | |
| IL289338A (en) | Therapeutic interactions of leucomethylthioninium | |
| GB202314911D0 (en) | Dosing of 5-MeO-DMT | |
| GB202405965D0 (en) | Dosing of 5-meO-DMT | |
| GB202403721D0 (en) | Dosing of 5-meo-dmt | |
| GB202403419D0 (en) | Dosing of 5-MeO-DMT | |
| IL291368A (en) | Inhibitor of metadherin expression | |
| ZA202105399B (en) | Use of spiropidion | |
| GB201910665D0 (en) | Novel form of compounds | |
| HK40092941A (en) | Dosing of fedratinib | |
| IL322676A (en) | Solid dosage forms of elafibranor | |
| GB202215264D0 (en) | Use of urolithins | |
| GB202308362D0 (en) | Semaglutide dosing | |
| GB202308365D0 (en) | Semaglutide dosing | |
| GB202203137D0 (en) | Kind of spoon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |